Ioflupane I-123 Completed Phase 3 Trials for Multiple System Atrophy (MSA) / Progressive Supranuclear Palsy (PSP) / Parkinson's Disease (PD) / Essential Tremor / Parkinsonian Syndromes Diagnostic

IndicationsStatusPurposePhase
CompletedDiagnostic3
clinicaltrials.gov IdentifierTitleDrugs
NCT04193527A Study to Evaluate the Diagnostic Efficacy of DaTSCAN™ Ioflupane (123I) Injection in Single Photon Emission Computed Tomography (SPECT) for the Diagnosis of Parkinsonian Syndrome (PS) in Chinese Patients